• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素I的纯化

The purification of hypertensin I.

作者信息

SKEGGS L T, MARSH W H, KAHN J R, SHUMWAY N P

出版信息

J Exp Med. 1954 Oct 1;100(4):363-70. doi: 10.1084/jem.100.4.363.

DOI:10.1084/jem.100.4.363
PMID:13201713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2136385/
Abstract

The purification of hypertensin I has been described. The final product which is four times as powerful a pressor agent as l-arterenol, is obtained with an over-all recovery of 40 per cent. The product consists of a single component in countercurrent distribution, having a nitrogen content of 15.97 per cent and a specific activity of 7050 Goldblatt units per mg. of N or 1125 units per mg. of solid. Acid hydrolysis and paper chromatography indicate in a preliminary fashion that there are about nine amino acids present in the intact polypeptide.

摘要

高血压素I的提纯方法已有报道。最终产物作为一种升压剂,其效力是去甲肾上腺素的四倍,总回收率为40%。该产物在逆流分配中为单一成分,含氮量为15.97%,比活性为每毫克氮7050戈德布拉特单位或每毫克固体1125单位。酸水解和纸层析初步表明,完整的多肽中约含有九种氨基酸。

相似文献

1
The purification of hypertensin I.血管紧张素I的纯化
J Exp Med. 1954 Oct 1;100(4):363-70. doi: 10.1084/jem.100.4.363.
2
The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I.血管紧张素II的氨基酸组成及其与血管紧张素I的生化关系。
J Exp Med. 1956 Aug 1;104(2):183-91. doi: 10.1084/jem.104.2.183.
3
The purification of hypertensin II.血管紧张素II的纯化
J Exp Med. 1956 Mar 1;103(3):301-7. doi: 10.1084/jem.103.3.301.
4
Amino acid composition and electrophoretic properties of hypertensin I.血管紧张素I的氨基酸组成和电泳特性。
J Exp Med. 1955 Oct 1;102(4):435-40. doi: 10.1084/jem.102.4.435.
5
The preparation and function of the hypertensin-converting enzyme.血管紧张素转换酶的制备与功能。
J Exp Med. 1956 Mar 1;103(3):295-9. doi: 10.1084/jem.103.3.295.
6
The amino acid sequence of hypertensin. II.高血压素II的氨基酸序列。二。
J Exp Med. 1956 Aug 1;104(2):193-7. doi: 10.1084/jem.104.2.193.
7
Amino-acid sequence in a hypertensin.高血压素中的氨基酸序列。
Nature. 1956 Mar 17;177(4507):527-8. doi: 10.1038/177527a0.
8
The amino acid sequence in a hypertensin.高血压素中的氨基酸序列。
Biochem J. 1957 Feb;65(2):246-54. doi: 10.1042/bj0650246.
9
The existence of two forms of hypertensin.高血压素两种形式的存在。
J Exp Med. 1954 Mar;99(3):275-82. doi: 10.1084/jem.99.3.275.
10
Renal pressor system in hypertension; evidence for circulating hypertensin in chronic renal hypertension; nature and activity of purified hypertensin.高血压中的肾升压系统;慢性肾性高血压中循环性高血压素的证据;纯化的高血压素的性质与活性。
Circulation. 1958 Apr;17(4, Part 2):658-63. doi: 10.1161/01.cir.17.4.658.

引用本文的文献

1
Nutritional Supplements for the Treatment of Neuropathic Pain.用于治疗神经性疼痛的营养补充剂。
Biomedicines. 2021 Jun 13;9(6):674. doi: 10.3390/biomedicines9060674.
2
Drug discovery in renin-angiotensin system intervention: past and future.肾素-血管紧张素系统干预中的药物研发:过去与未来
Ther Adv Cardiovasc Dis. 2016 Jun;10(3):118-25. doi: 10.1177/1753944716642680. Epub 2016 Apr 27.
3
Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.血管紧张素转换酶插入/缺失多态性与糖尿病和非糖尿病肾病中的肾脏保护作用
Clin J Am Soc Nephrol. 2008 Sep;3(5):1511-25. doi: 10.2215/CJN.04140907. Epub 2008 Jun 11.
4
Isolation and identification of a pepsitensin.一种胃紧张素的分离与鉴定。
Biochem J. 1965 Nov;97(2):540-6. doi: 10.1042/bj0970540.
5
Ace revisited: a new target for structure-based drug design.再探Ace:基于结构的药物设计新靶点。
Nat Rev Drug Discov. 2003 Nov;2(11):891-902. doi: 10.1038/nrd1227.
6
THE CHEMISTRY OF RENIN SUBSTRATE.肾素底物的化学性质
Can Med Assoc J. 1964 Jan 25;90(4):185-9.
7
The purification and partial characterization of several forms of hog renin substrate.几种形式的猪肾素底物的纯化及部分特性分析
J Exp Med. 1963 Jul;118(1):73-98. doi: 10.1084/jem.118.1.73.
8
[Renin and hypertension, physiological or pathological agents?].[肾素与高血压,生理因素还是病理因素?]
Klin Wochenschr. 1958 Aug 1;36(15):693-706. doi: 10.1007/BF01493136.
9
The synthesis of a tetradecapeptide renin substrate.一种十四肽肾素底物的合成。
J Exp Med. 1958 Sep 1;108(3):283-97. doi: 10.1084/jem.108.3.283.
10
The preparation, purification, and amino acid sequence of a polypeptide renin substrate.一种多肽肾素底物的制备、纯化及氨基酸序列
J Exp Med. 1957 Sep 1;106(3):439-53. doi: 10.1084/jem.106.3.439.

本文引用的文献

1
THE RENAL HUMORAL PRESSOR MECHANISM IN MAN. I. PREPARATION AND ASSAY OF HUMAN RENIN, HUMAN HYPERTENSINOGEN, AND HYPERTENSIN.人类的肾素 - 血管紧张素升压机制。一、人肾素、人血管紧张素原及血管紧张素的制备与测定
J Clin Invest. 1945 Jan;24(1):62-8. doi: 10.1172/JCI101579.
2
Artificial kidney; construction and operation of an improved continuous dialyzer.人工肾;一种改进型连续透析器的构造与操作
Proc Soc Exp Biol Med. 1949 Dec;72(3):539-43. doi: 10.3181/00379727-72-17491.
3
The assay of hypertensin from the arterial blood of normotensive and hypertensive human beings.对正常血压和高血压人群动脉血中高血压素的测定。
J Exp Med. 1952 Jun;95(6):523-9. doi: 10.1084/jem.95.6.523.
4
The isolation and assay of hypertensin from blood.从血液中分离和测定高血压素。
J Exp Med. 1952 Mar;95(3):241-6. doi: 10.1084/jem.95.3.241.
5
The isolation of hypertensin from the circulating blood of normal dogs with experimental renal hypertension by dialysis in an artificial kidney.通过人工肾透析从患有实验性肾性高血压的正常犬的循环血液中分离高血压素。
Circulation. 1951 Mar;3(3):384-9. doi: 10.1161/01.cir.3.3.384.
6
The extraction and purification of hypertension (angiotonin).高血压(血管紧张素)的提取与纯化。
J Biol Chem. 1954 Feb;206(2):717-24.
7
The existence of two forms of hypertensin.高血压素两种形式的存在。
J Exp Med. 1954 Mar;99(3):275-82. doi: 10.1084/jem.99.3.275.
8
A method of assaying small amounts of hypertensin.一种检测少量高血压素的方法。
Lab Invest. 1953 Mar-Apr;2(2):109-14.
9
Countercurrent distribution.逆流分布
Methods Med Res. 1952;5:3-24.